Not all New Zealanders are achieving best health outcomes from medicines funded by PHARMAC. We don’t think this is acceptable, so we’re striving to eliminate inequities in access to medicines by 2025.
Right now, we’re focusing on understanding why people don’t – or can’t – access funded medicines, starting with population groups that we know face health inequities. This will help us make it so everyone can have a fair opportunity to access funded medicines.
We've developed a discussion paper about why people are missing out on funded medicines. We'd appreciate your feedback.
We also commissioned a literature review to identity barriers in access to medicines:
We can’t achieve this alone – we have to work together across the health system.
If you want to learn more about what improved medicine access equity means, contact our Access Equity team at firstname.lastname@example.org.
Aim - To eliminate inequities in access to medicines by 2025
|Primary drivers||Secondary drivers||PHARMAC's role|
|Medicine availability||PHARMAC’s decision making processes for investment in medicines||Control|
|Funding restrictions and schedule rules||Control|
|Prescriber awareness of funded medicine(s) available||Role|
|Medicine accessibility||Physical & timely access to a prescriber/prescription||Influence|
|Physical & timely access to a community pharmacy||Influence|
|Physical & timely access to diagnostic and monitoring services, eg labs, scans||Influence|
|Medicine affordability||Prescriber costs, eg consult, repeat prescription & medicine administration fees||Influence|
|Prescription costs, eg co-payment, blister pack costs, prescription subsidy card||Influence|
|Indirect costs, eg transport, time off work, childcare||Influence|
|Medicine acceptability||Patient/whānau experiences bias from the health system||Influence|
|Beliefs and perceptions of treatment prescribed not adequately explored/sought||Role|
|Medicine suitability not adequately considered||Role|
|Patient/whānau is not empowered with knowledge about the medicine(s)||Role|
|Medicine appropriateness||Medicine therapy prescribed is inadequate||Role|
|Unwarranted variation in prescribing||Role|
|PHARMAC has control||PHARMAC has a role||PHARMAC has influence|
Last updated: 5 September 2019